MELBOURNE, April 04, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research completed a qualitative study titled "Autism Therapy Market" with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy to grasp full analysis. A steadfast Autism Therapy market research report serves to be a very momentous component of business strategy. This report provides important information which assists to identify and analyze the needs of the market, the market size, and the competition with respect to Autism Therapy industry. When the market report is accompanied with precise tools and technology, it helps tackle a number of uncertain challenges for the business. This market research report is one of the key factors used in maintaining competitiveness over competitors. Autism Therapy market report supports the business to take better decisions for the successful future planning in terms of current and future trends in particular product or the industry.
Data Bridge Market Research analyses that the autism therapy market, which was USD 2.05 billion in 2022, would rise to USD 3.42 billion by 2030 and is expected to undergo a CAGR of 6.60% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download a PDF Sample of the Autism Therapy Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-autism-therapy-market
Autism therapies are the type of therapies that are applied in autistic children or adults to improve or enhance their condition. Different therapies include speech-language therapy, behavior therapy, play-based therapy, occupational therapy, physical therapy, and nutritional therapy. This neurological disorder is related to several disabilities, such as challenges with the individual's behavior or lack of social skills. The diagnosis of autism can be made from a very early age, but the cause is still unknown.
The growing incidence of autism and pervasive developmental disorder (PDD) is essential to escalate market growth. Huge research studies performed by organizations to assess the safety and efficiency of drugs in patients with ASD are anticipated to boost market growth. The stimulants segment dominated the market with a huge revenue share due to the wide availability and ease of accessibility of drugs to patients.
Fundamental Aim of Autism Therapy Market Report
In the Autism Therapy market, every company has goals, but this report focus in on the most important ones, allowing you to gain insight into the competition, the future of the market, potential new products, and other useful information that can boost your sales significantly.
- Factors influencing the Autism Therapy Market Size and growth rate.
- Major alterations to the Autism Therapy Market in the near future.
- Notable Market rivals around the world.
- The Autism Therapy Market's Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
- Sales data and profiles of the world's leading Autism Therapy Players
Some of the major players operating in the autism therapy market are:
- Pfizer Inc. (U.S.)
- Lilly (U.S.)
- Abbvie, Inc (U.S.)
- Merck & Co., Inc (U.S.).
- Teva Pharmaceutical Industries Ltd.(Israel)
- Novartis AG (Switzerland)
- Johnson & Johnson Services, Inc (U.S.).
- Hopebridge, LLC (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Otsuka America Pharmaceutical, Inc (Japan)
- Curemark, LLC (U.S.).
- Sosei Group Corporation (Japan)
- Sun Pharmaceutical Industries Ltd.(India)
- Mylan N.V. (U.S.).
- Endo International plc (Ireland)
- F. Hoffmann-La Roche Ltd (Switzerland)
Recent Development
- In 2022, Bened Life launched the first gut-brain medical probiotic named Neuralli. Neuralli is designed to raise awareness about mental health and support neurological conditions including but not limited to Parkinson's disease (P.D.) and autism spectrum disorder (ASD).
- In 2022, STALICLA, a Swiss clinical-stage biotech company leading omics-based drug development for patients with neurodevelopmental disorders (NDDs), stated the highly successful completion of the phase 1b trials for its lead drug candidate STP1.
Download the Complete Research Study Here in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-autism-therapy-market
The investment made in the study would provide you access to information such as:
- Autism Therapy Market [Global – Broken-down into regions]
- Regional level split [North America, Europe, Asia Pacific, South America, Middle East & Africa]
- Country wise Market Size Split [of important countries with major market share]
- Market Share and Revenue/Sales by leading players
- Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, etc.
- Autism Therapy Market Size
- Market Size by application/industry verticals
- Market Projections/Forecast
Opportunities:
- Increasing Demand for Stimulants
The increasing demand for stimulants is boosting the growth of the market. Adderall, Focalin, Vyvanse, Dexedrine, and Ritalin are some stimulants approved by the U.S. FDA for treating patients who have autism. These drugs improve patient behavior by 80% when administered properly to patients. Therefore, growing efficiency related to the stimulants may attract a new target population and boost market growth.
- Increasing Product Launches
A growing number of product launches associated with autism therapy boost market growth. For instance, the FDA granted fast-track designation to Curemark's CM-AT specified for ASD in 3-8 years old children in 2022. Furthermore, Indian researchers developed the 6BIO compound in 2021, which has shown the potential to enhance daily activities in the pre-clinical investigation of patients with an autism spectrum disorder. Thus, this factor boosts market growth.
Key Growth Drivers:
- Increasing Rate of Autistic Population
The increasing incidence of the autistic population is boosting the market's growth. For instance, France and Portugal have the lowest rates of autism in the world, with approximately 0.69% and 0.71%, respectively, as per the research published by Health Data Exchange. In 2021, the CDC stated that nearly 1 in 44 children in the U.S. is diagnosed with an autism spectrum disorder (ASD). Thus, this increasing prevalence demands high adoption of therapies, boosting the market growth.
- Increasing R&D Activities Associated with Autism Therapy
Huge research studies performed by organizations to assess the safety and efficacy of drugs in patients with ASD are anticipated to drive the market. The positive outcomes of these studies lead to new growth opportunities for the market. For instance, Stalicla completed phase 1b trials of precision medicine candidate STP1 and witnessed positive results with symptom improvement in patients with ASD in 2022. Therefore, the effective completion of the trial and following product approvals are estimated to drive the market. Thus, this factor boosts market growth.
Read the In-Depth Research Report @ https://www.databridgemarketresearch.com/reports/global-autism-therapy-market
Key Market Segments Covered in Autism Therapy Industry Research
Age Group
- Child
- Adult
Type
- Asperger Syndrome
- Pervasive Developmental Disorder
- Autistic Disorder
Treatment Type
- ABA
- Hyperbaric Oxygen Therapy
- Chelation Therapy
- Oxytocin Therapy
Drug
- Carbamazepine
- Oxcarbazepine
- Lamotrigine
- Antipsychotics
- Amisulpride.
- Aripiprazole.
- Asenapine
- Insomnia Drugs
- Triazolam
- Estazolam
- SSRIs
- Citalopram
- Dapoxetine
- Escitalopram
- Stimulants
Distribution Channel
- Hospital & Clinics
- Retail Pharmacies
- Online Pharmacies
Autism Therapy Market Regional Analysis/Insights:
The countries covered in the autism therapy market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the autism therapy market due to increasing R&D activities and the launching several new products through mergers and strategic partnerships in this region. Also, the increasing awareness about the availability of numerous therapies to treat patients with autism spectrum disorders in this region
Asia-Pacific is expected to witness significant growth due to the wide presence of major market players and strategic initiatives undertaken by them to develop and commercialize several new products to treat patients. For instance, Teijin Pharma and Hamamatsu Medical University confirmed the safety, efficiency, and tolerability of oxytocin nasal spray for treating patients with an autism spectrum disorder in 2022
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Global Autism Therapy Market: Regulations
- Market Overview
- Global Autism Therapy Market, By Age Group
- Global Autism Therapy Market, By Type
- Global Autism Therapy Market, By Treatment Type
- Global Autism Therapy Market, By Drug
- Global Autism Therapy Market, By Distribution Channel
- Global Autism Therapy Market, By Region
- Global Autism Therapy Market: Company Landscape
- SWOT Analyses
- Company Profile
- Questionnaires
- Related Reports
For The Entire Table of Contents, Click Here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-autism-therapy-market
Explore More Reports:
- Autism Drug Market, By Type (Asperger Syndrome, Pervasive Developmental Disorder, Autistic Disorder), Mechanism of Action (Antipsychotics, Anticonvulsants, Antidepressants, Stimulants, Others), Drugs Type (Risperidone, Fluoxetine, Clomipramine, Methylphenidate, Phenytoin, Others), Therapy Type (Behavioral Therapy, Occupational Therapy, Physical Therapy, Speech Therapy, Others), Route of Administration (Oral, Intravenous, Others), Distribution Channel (Online Pharmacy, Direct Tenders), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-autism-drug-market
- Cell Therapy Market, By Technology (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, Three-Dimensional Technology), Type (Autologous, Allogeneic), Cell Source (iPSCs, Bone Marrow, Umbilical Cord Blood-Derived Cells, Adipose Tissues, Neural Stem Cell), Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Wounds & Injuries, Ocular, Others), End-User (Hospitals & Clinics, Regenerative Medicine Centers, Diagnostic & Research Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-cell-therapy-market
- Anticoagulation Therapy Market, By Treatment (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Arterial Thromboembolism (AT), Stroke, Others), Therapeutic Class (Novel Oral Anticoagulants (NOAC), Heparin, Vitamin K Antagonists, Others), Drug Type (Bivalirudin, Dabigatran, Edoxaban, Betrixaban, Rivaroxaban, Apixaban, Enoxaparin, Dalteparin, Others), Route of Administration (Oral, Parenteral), Therapeutic Area (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others), Procedure (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Heart Valve Replacement), Type (Generics, Branded), End User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-anticoagulation-therapy-market
- Iron-Deficiency Anemia Therapy Market, By Therapy (Parenteral Iron Therapy, Oral Iron Therapy), Therapy Areas (Inflammatory Bowel Disease, Renal, Obstetrics, and Gynecology, Congestive Heart Failure (CHF), Oncology, Others) Population (Adults, Pediatric, Geriatric), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) https://www.databridgemarketresearch.com/reports/global-iron-deficiency-anemia-therapy-market
- Hyperbaric Oxygen Therapy (HBOT) Market, By Product Type (Monoplace HBOT, Multiplace HBOT and Topical HBOT devices), Application (Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism and Others), End-Use (Hospitals and Clinics, Ambulatory Surgery Centres and Others) https://www.databridgemarketresearch.com/reports/global-hyperbaric-oxygen-therapy-hbot-market
- Image-Guided Radiation Therapy Market, By Type (Soft-Tissue Imaging, Lung MRI, Simplifying Cardiac MRI, Simplifying MRI-Conditional Implant Scans, Silent MRI Scanning, Others), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer, Others), Technology (Radiation-Based System, Non-Radiation Based System, Others), Devices (X-Ray CT, MRI, PET, Others), End-Users (Hospitals, Smart Cancer Centers, Research Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-image-guided-radiation-therapy-market
- Proton Therapy Market, By Product Type (Systems, Software, Services), Component (Proton Accelerator, Beam Transport System, Beam Delivery System, Nozzle, Image Viewers, Patient Positioning System (PPS)), Type (Rotating Proton Therapy Systems, Non Rotating Proton Therapy Systems), Set-Up Systems (Multi-Room Systems, Compact/ Single-Room Systems), Application Type (Treatment Applications, Research Applications), End User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-proton-therapy-market
- Laser Therapy Market, By Type (Diode Lasers, Solid State Lasers, Liquid Lasers, Semiconductor Lasers, Gas Lasers, Dye Lasers and Others), Application (Dermatology and Aesthetics, Surgery, Gynaecology, Dental, Urology, Ophthalmology, Cardiovascular and Others), End User (Hospitals, Specialized Clinics, Ambulatory Surgical Centres and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-laser-therapy-market
- Particle Therapy Market, By Therapy Type (Proton Therapy, Heavy Ion Therapy, Fast-Neutron Therapy), Component Type (Products, Services), System (Multi-Room Systems, Single-Room Systems), Cancer Type (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Other Cancers), Application (Treatment Application, Research Application), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-particle-therapy-market
- Electrotherapy Market, By Technology (Transcutaneous Electrical Nerve Stimulation (TENS), Neuromuscular Electrical Stimulation (NMES), Inferential Current (IFC), Percutaneous Electrical Nerve Stimulation (PENS), Electronic Muscle Stimulator (EMS), Spinal Cord Stimulation (SCS), Electro-acupuncture (EA), Others), Application (Chronic Wound Healing, Neuromuscular Dysfunction, Pain Management, Tissue Repair, Musculoskeletal Disorder, Physical Therapy, Iontophoresis, Others), Therapy (Extracorporeal Shock Wave Therapy, Magnetic Field Therapy, Ultrasound Therapy, Micro current Therapy, Interferential Current Therapy, Others), End-User (Hospitals, Rehabilitation Centres, Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-electrotherapy-market
- Compression Therapy Market, By Technique (Static Compression Therapy, Dynamic Compression Therapy), Product (Compression Garments, Compression Tapes, Compression Pumps, Compression Braces, Compression Pumps), Application (Varicose Vein Treatment, Deep Vein Thrombosis Treatment, Lymphedema Treatment, Leg Ulcer Treatment, Others), End User (Pharmacies and Retailers, Hospitals and Clinics, E-Commerce Platforms) https://www.databridgemarketresearch.com/reports/global-compression-therapy-market
- Europe Compression Therapy Market, By Product (Compression Braces, Compression Pumps, Compression Garments), Technique (Static Compression Therapy, Dynamic Compression Therapy), Application (Lymphedema Treatment, Leg Ulcer Treatment, Varicose Vein Treatment, Deep Vein Thrombosis Treatment, Other), End User (Pharmacies and Retailers, Hospitals and Clinics, E-Commerce Platforms), Country (Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland and Rest of Europe) https://www.databridgemarketresearch.com/reports/europe-compression-therapy-market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
